Loxapine Succinate and Moxetumomab Pasudotox-tdfk
Determining the interaction of Loxapine Succinate and Moxetumomab Pasudotox-tdfk and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: loxapine
Brand name: Loxitane, Adasuve
Synonyms: Loxapine
Generic Name: moxetumomab pasudotox
Brand name: Lumoxiti
Synonyms: Moxetumomab pasudotox, Moxetumomab Pasudotox
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Loxapine Succinate-Moxetumomab pasudotox-tdfk Intravenous
- Loxapine Succinate-Moxifloxacin
- Loxapine Succinate-Moxifloxacin (Systemic)
- Loxapine Succinate-Moxifloxacin Hydrochloride
- Loxapine Succinate-Moxifloxacin Injection
- Loxapine Succinate-Moxifloxacin Intravenous
- Moxetumomab Pasudotox-tdfk-Loxitane
- Moxetumomab Pasudotox-tdfk-Lozol
- Moxetumomab Pasudotox-tdfk-LTA II Kit
- Moxetumomab Pasudotox-tdfk-Lubiprostone
- Moxetumomab Pasudotox-tdfk-Lucemyra
- Moxetumomab Pasudotox-tdfk-Lucentis